Centene Corporation Advises Stockholders to Reject TRC Capital's Mini-Tender Offer

TRC Capital Investment Corporation made an unsolicited offer on August 5, 2025, proposing to purchase up to 4 million shares of Centene's common stock at a price of $24.75 per share. This offer is set to expire on September 4, 2025, although TRC has the option to extend the offer. Notably, the proposed purchase price is below the current market value of Centene’s shares, which has raised concerns regarding the attractiveness of this offer for stockholders.

Centene has strongly recommended that its stockholders reject the mini-tender offer from TRC. The company has emphasized the importance of assessing the current market price of their shares and encourages investors to consult with their financial advisors before making any decisions. This recommendation highlights Centene's commitment to protecting the interests of its shareholders and ensuring they make informed choices regarding their investments.

In conjunction with Centene's announcement, the U.S. Securities and Exchange Commission (SEC) issued a notice advising investors to carefully evaluate mini-tender offers. According to the SEC, mini-tender offers — defined as proposals to purchase less than 5% of a company's outstanding shares — may lead investors to sell their shares at prices lower than the market value. This advisory serves as a critical reminder for investors to exercise due diligence when considering such offers.

For stockholders who may have already tendered their shares to TRC's offer, Centene has outlined a process for withdrawal. Investors can rescind their tendered shares by providing written notice as specified in TRC's offering documents prior to the expiration date of the offer. This option ensures that stockholders can retain control over their investments and avoid potential losses.

Centene Corporation is a Fortune 500 company renowned for its commitment to providing high-quality and cost-effective healthcare services. The company focuses on serving government-sponsored and commercial healthcare programs, particularly for under-insured and uninsured individuals. With a local approach, Centene offers a range of healthcare products including Medicaid and Medicare services, impacting the lives of more than one in fifteen individuals across the United States.

For additional information on Centene’s financial performance and other important updates, the company maintains an investor relations website where stakeholders can access relevant materials and reports.

As Centene Corporation navigates the unsolicited mini-tender offer from TRC Capital Investment Corporation, the company's proactive stance in advising stockholders to reject the offer underscores its commitment to safeguarding shareholder interests. Investors are encouraged to stay informed and consult their financial advisors to make the best choices for their portfolios as the September 4 deadline approaches.